Dietary, environmental, and genetic risk factors of Extensive Macular Atrophy with Pseudodrusen, a severe bilateral macular atrophy of middle-aged patients

Archive ouverte

Douillard, Aymeric | Picot, Marie-Christine | Delcourt, Cécile | Defoort-Dhellemmes, Sabine | Marzouka, Nour Al-Dain | Lacroux, Annie | Zanlonghi, Xavier | Drumare, Isabelle | Jozefowicz, Elsa | Bocquet, Béatrice | Baudoin, Corinne | Perez-Roustit, Sarah | Arsène, Sophie | Gissot, Valérie | Devin, François | Arndt, Carl | Wolff, Benjamin | Mauget-Faÿsse, Martine | Quaranta, Maddalena | Mura, Thibault | Deplanque, Dominique | Oubraham, Hassiba | Cohen, Salomon Yves | Gastaud, Pierre | Zambrowski, Olivia | Creuzot-Garcher, Catherine | Saïd, Saddek Mohand | Sahel, José-Alain | Souied, Eric | Milazzo, Solange | Garavito, Rocio Blanco | Kalatzis, Vasiliki | Puech, Bernard | Hamel, Christian | Audo, Isabelle | Meunier, Isabelle

Edité par CCSD ; Nature Publishing Group -

Open access article 10 p.. International audience. EMAP (Extensive Macular Atrophy with Pseudodrusen) is a maculopathy we recently described that shares pseudodrusen and geographic atrophy with Age-related Macular Disease (AMD). EMAP differs from AMD by an earlier age of onset (50-55 years) and a characteristic natural history comprising a night blindness followed by a severe visual loss. In a prospective case-control study, ten referral centers included 115 EMAP (70 women, 45 men) patients and 345 matched controls to appraise dietary, environmental, and genetic risk factors. The incidence of EMAP (mean 2.95/1.106) was lower in Provence-Côte d'Azur with a Mediterranean diet (1.9/1.106), and higher in regions with intensive farming or industrialized activities (5 to 20/1.106). EMAP patients reported toxic exposure during professional activities (OR 2.29). The frequencies of common AMD complement factor risk alleles were comparable in EMAP. By contrast, only one EMAP patient had a rare AMD variant. This study suggests that EMAP could be a neurodegenerative disorder caused by lifelong toxic exposure and that it is associated with a chronic inflammation and abnormal complement pathway regulation. This leads to diffuse subretinal deposits with rod dysfunction and cone apoptosis around the age of 50 with characteristic extensive macular atrophy and paving stones in the far peripheral retina.

Suggestions

Du même auteur

Clinical characteristics and risk factors of extensive macular atrophy with pseudodrusen The EMAP case-control national clinical trial

Archive ouverte | Douillard, Aymeric | CCSD

Purpose: To assess the association of clinical and biological factors with extensive macular atrophy with pseudodrusen (EMAP) characterized by bilateral macular atrophy occurring in patients aged 50 to 60 years and a rapid progres...

A new autosomal dominant eye and lung syndrome linked to mutations in TIMP3 gene

Archive ouverte | Meunier, Isabelle | CCSD

International audience. To revisit the autosomal dominant Sorsby fundus dystrophy (SFD) as a syndromic condition including late-onset pulmonary disease. We report clinical and imaging data of ten affected individual...

High prevalence of PRPH2 in autosomal dominant retinitis pigmentosa in France and characterization of biochemical and clinical features.

Archive ouverte | Manes, Gaël | CCSD

International audience. PURPOSE:To assess the prevalence of PRPH2 in autosomal dominant retinitis pigmentosa (adRP), to report six novel mutations, to characterize the biochemical features of a recurrent novel mutat...

Chargement des enrichissements...